Global Vascular Embolization Devices Market 2024-2028

Global Vascular Embolization Devices Market 2024-2028

The vascular embolization devices market is forecasted to grow by USD 735.35 mn during 2023-2028, accelerating at a CAGR of 6.69% during the forecast period. The report on the vascular embolization devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of vascular diseases, a rising number of new product launches related to vascular embolization devices, and a growing number of m and activities in related vascular disease products.

Technavio's vascular embolization devices market is segmented as below:

By End-user

• Hospitals
• Speciality clinics
• ASCs

By Product

• Coiling devices
• Non-coiling devices

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rise in cases of automobile accidents as one of the prime reasons driving the vascular embolization devices market growth during the next few years. Also, funding for start-up embolization device companies from venture capitalists and government organizations and innovation in embolization products and procedures will lead to sizable demand in the market.

The report on the vascular embolization devices market covers the following areas:

• Vascular embolization devices market sizing
• Vascular embolization devices market forecast
• Vascular embolization devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vascular embolization devices market vendors that include Acandis GmbH, B.Braun SE, BALT Group, Boston Scientific Corp., Braile Biomedica, Eisai Co. Ltd., Embolx Inc., Guerbet, Johnson and Johnson Services Inc., Kaneka Corp., Medtronic, Merit Medical Systems Inc., Penumbra Inc., Shape Memory Medical Inc., Spartan Micro Inc., Stryker Corp., Wallby Medical LLC, Terumo Corp., Cook Group Inc., and Abbott Laboratories. Also, the vascular embolization devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.